FDA Approval The latest news regarding FDA applications, processes, and approval. This section contains releases regarding the Food and Drug Administration’s consideration of new products, drugs, therapies and treatments. Find announcements covering every stage of the FDA application process, from filing to eventual approval, including appeals, resubmissions, and safety alerts.

Sep 04, 2015

08:15 ET

Sep 03, 2015

17:49 ET

Sep 03, 2015

10:57 ET

Quest Diagnostics Incorporated logo.

Sep 02, 2015

12:56 ET

NxThera, Inc. Logo

Sep 02, 2015

09:06 ET

SIMPONI ARIA(R) (golimumab for infusion)

Sep 02, 2015

08:00 ET

ReShape Logo

Sep 02, 2015

07:15 ET

Sep 02, 2015

06:45 ET

Sep 02, 2015

02:15 ET

Sep 02, 2015

02:15 ET

Sep 01, 2015

09:00 ET

Sep 01, 2015

07:15 ET

Sep 01, 2015

05:22 ET

PharmaMar Grupo Zeltia Logo

Sep 01, 2015

05:08 ET

PharmaMar Grupo Zeltia Logo

Aug 31, 2015

07:00 ET

Aug 31, 2015

06:00 ET

Aug 30, 2015

09:22 ET

Aug 29, 2015

13:20 ET

Aug 28, 2015

13:23 ET

Aug 28, 2015

07:00 ET

The MagVita TMS Therapy system from MagVenture which is here seen, has of July 31 2015 been cleared by the US Food and Drug Administration for the treatment of Major Depressive Disorder in adult patients who have failed to receive satisfactory improvement from prior antidepressant medication in the current episode. (PRNewsFoto/MagVenture)

Jump to news releases